Novel approaches to immunotherapy using thymic peptides

Immunology Today

Volumn 18, Issue 1, 1997, Pages 10-13

  Cordero, Oscar J ^a   Nogueira, Montserrat ^a   Maurer, H Rainer ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THYMOPENTIN; THYMOPOIETIN; THYMOSIN; THYMULIN; THYMUS PEPTIDE;

AUTOIMMUNITY; CANCER; CONFERENCE PAPER; DRUG THERAPY; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031015369     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(97)80007-2     Document Type: Conference Paper

References (10)

1. Boehm T., Nehls M., Kyewsky B. Immunol. Today. 16:1995;555-556.
2. Kendall M.D. J. Anat. 177:1991;1-29.
3. Zevin-Sonkin D., Ilan E., Guthmann D., Riss J., Theodor L., Shoham J. Immunol. Lett. 31:1992;301-310.
4. Burstein Y., Buchner V., Pecht M., Trainin N. Biochemistry. 27:1988;4066-4071.
5. Goldstein A.L. Goldstein A.L., Garaci E. Combination Therapies 2. Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases. 1993;39-48 Plenum Press.
6. Haritos A.A., Goodall G.J., Horecker B.L. Proc. Natl. Acad. Sci. U. S. A. 81:1984;1008-1011.
7. Hobbs J.R., Byrom N.A., Chambers J.D., Williamson S.A., Nagvekar N. Byron N.A., Hobbs J.R. Thymic Factor Therapy. 1984;187-190 Raven Press.
8. McKall C.L., Fleisher T.A., Brown M.R., et al. New Engl. J. Med. 322:1995;143-149.
9. Baxevanis C.N., Gritzapis A.D., Spanakos G., Tsitsilonis O.E., Papamichail M. Cancer Immunol. Immunother. 40:1995;410-418.
10. Ramachandran R., Katzenstein D.A., Winters M.A., Kundu S.K., Merigan T.C. J. Infect. Dis. 173:1996;1005-1008.